Non-viral RNA treatment approaches in Cancer Immunotherapy

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/37/d8/7a/37d87ae2-af3e-0213-e439-57905d10d0b0/mza_13754466389719225512.jpg/600x600bb.jpg

Immuno Oncology Talks

Sanofi

11 episodes

7 months ago

In the current episode of “Immuno Oncology Talks”, we discuss the clinical challenges and future perspectives of CAR-T cells with our experts, from the Oslo University Hospital in Norway, Dr Else Marit Inderberg and Dr Sébastien Wälchli. Dr Inderberg is the head of the immunomonitoring at the hospital and has a research focus on novel immunotherapies, and Dr Wälchli is leading the CAR development platform. MAT-BE-2400334 (ver.1.0) 04 2024

Health & Fitness

Education

RSS

All content for Immuno Oncology Talks is the property of Sanofi and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Health & Fitness

Education

Non-viral RNA treatment approaches in Cancer Immunotherapy

Immuno Oncology Talks

29 minutes

2 years ago

Non-viral RNA treatment approaches in Cancer Immunotherapy

In our sixth episode of “Immuno Oncology Talks”, we will discuss non-viral RNA treatment approaches in cancer immunotherapy with our guest, professor Karine Breckpot from the Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, in Belgium. Professor Breckpot has a strong background within innovative immunotherapy strategies in cancer, and especially with mRNA technologies as a way to target the immune system. MAT-BE-2300154 (ver.1.0)...